Insider Curtis Ross sells 20,000 RenaissanceRe (RNR) shares under plan

Rhea-AI Filing Summary

RenaissanceRe Holdings executive vice president and chief portfolio officer Curtis Ross reported open-market sales of 20,000 shares of company common stock on February 4–5, 2026.

The shares were sold in four 5,000-share blocks at prices of $290, $295, $300 and $305 per share under a Rule 10b5-1 trading plan adopted on November 24, 2024. After these transactions, Ross beneficially owns 166,813 shares of RenaissanceRe common stock directly.

Insider Trade Summary

Net Seller: 20,000 shares ($5,950,000)

Net Sell 4 txns

Insider Curtis Ross

Role EVP,Chief Portfolio Officer

Sold 20,000 shs ($5.95M)

Type	Security	Shares	Price	Value
Sale	Common Stock	5,000	$305.00	$1.52M
Sale	Common Stock	5,000	$290.00	$1.45M
Sale	Common Stock	5,000	$295.00	$1.48M
Sale	Common Stock	5,000	$300.00	$1.50M

Holdings After Transaction: Common Stock — 166,813 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Curtis Ross

(Last) (First) (Middle)

RENAISSANCE HOUSE

12 CROW LANE

(Street)

PEMBROKE D0 HM 19

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RENAISSANCERE HOLDINGS LTD [ RNR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP,Chief Portfolio Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/04/2026		S(1)		5,000	D	$290	181,813	D
Common Stock	02/04/2026		S(1)		5,000	D	$295	176,813	D
Common Stock	02/04/2026		S(1)		5,000	D	$300	171,813	D
Common Stock	02/05/2026		S(1)		5,000	D	$305	166,813	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. All sales were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 24, 2024.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Molly E. Gardner, Attorney-in-Fact	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Curtis Ross report for RenaissanceRe (RNR)?

Curtis Ross reported selling 20,000 RenaissanceRe common shares. The EVP and chief portfolio officer disclosed four sales of 5,000 shares each on February 4–5, 2026, at prices between $290 and $305 per share, according to the Form 4 filing.

Over what dates did the RNR insider stock sales by Curtis Ross occur?

The reported RenaissanceRe insider sales occurred on February 4–5, 2026. Curtis Ross executed three 5,000-share sales on February 4 and one 5,000-share sale on February 5, as detailed in the Form 4 transaction table.

At what prices did Curtis Ross sell RenaissanceRe (RNR) shares?

Ross’s reported RenaissanceRe share sales ranged from $290 to $305. The Form 4 lists sales of common stock at $290, $295, $300, and $305 per share, each involving 5,000 shares in open-market transactions.

How many RenaissanceRe (RNR) shares does Curtis Ross hold after these sales?

Curtis Ross beneficially owns 166,813 RenaissanceRe shares after the sales. The Form 4 indicates this direct ownership balance following the final 5,000-share sale reported on February 5, 2026.

Were Curtis Ross’s RenaissanceRe (RNR) stock sales under a 10b5-1 plan?

Yes, the filing states all sales were under a Rule 10b5-1 plan. The explanation notes that each reported transaction was effected pursuant to a trading plan adopted by Ross on November 24, 2024.